A leading developer of precision vascular robotics, Corindus Vascular Robotics said that the Journal of American College of Cardiology was publishing a study that evaluated the use of its robotic assisted angioplasty procedures.
The study was designed as a single-arm, open label, prospective trial to evaluate the safety and technical efficacy of the CorPath 200 System that the company had developed. It considered how the system delivered and manipulated coronary guidewires and stent or balloon systems in percutaneous coronary intervention procedures.
The study was conducted at the Corbic Research Institute in Envigado, Colombia by Dr. Giora Weisz and Dr. Juan Granada. The CorPath 200 System used to perform the procedures, achieved a technical success rate of 97.9 percent. Patients were discharged within 24 hours of the intervention and a 30 day follow up brought no major adverse cardiovascular events.
The study was first presented at the Transcatheter Cardiovascular Therapeutics 2010 conference in September. Dr. Granada who served as lead investigator is the medical director of the Skirball Center for Cardiovascular Research, Cardiovascular Research Foundation in Orangeburg, N.Y. He said that the trials showed a 100 % clinical success rate. He added that it was a significant evolution in the interventional device technologies as the procedure had remained unchanged in the last 25 years.